These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15946548

  • 61. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.
    Li C, Shintani S, Terakado N, Klosek SK, Ishikawa T, Nakashiro K, Hamakawa H.
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):559-65. PubMed ID: 16053878
    [Abstract] [Full Text] [Related]

  • 62. [Expressions of hypoxia inducible factor-1alpha and insulin-like growth factor-II in gastric carcinoma: correlation with angiogenesis and prognosis].
    Ru GQ, Zhao ZS, Tang QL, Xu WJ.
    Zhonghua Wai Ke Za Zhi; 2007 Jul 01; 45(13):905-8. PubMed ID: 17953839
    [Abstract] [Full Text] [Related]

  • 63. [Clinicopathological significance of expressions of RECK and MMP-2 in esophageal squamous carcinoma].
    Qi M, Li JS, Li Y.
    Zhonghua Zhong Liu Za Zhi; 2010 Apr 01; 32(4):283-5. PubMed ID: 20510080
    [Abstract] [Full Text] [Related]

  • 64. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
    McCawley LJ, Crawford HC, King LE, Mudgett J, Matrisian LM.
    Cancer Res; 2004 Oct 01; 64(19):6965-72. PubMed ID: 15466188
    [Abstract] [Full Text] [Related]

  • 65. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
    Hu SE, Zhang YJ, Cui YM, Zhang HQ.
    Ai Zheng; 2005 Sep 01; 24(9):1076-9. PubMed ID: 16159428
    [Abstract] [Full Text] [Related]

  • 66. Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas.
    Wittekindt C, Jovanovic N, Guntinas-Lichius O.
    Acta Otolaryngol; 2011 Jan 01; 131(1):101-6. PubMed ID: 20873997
    [Abstract] [Full Text] [Related]

  • 67. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
    Li Z, Bian LJ, Li Y, Liang YJ, Liang HZ.
    Pathol Res Pract; 2009 Jan 01; 205(8):542-50. PubMed ID: 19269113
    [Abstract] [Full Text] [Related]

  • 68. Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater.
    Chen L, Tao SF, Zheng YX.
    Hepatogastroenterology; 2006 Jan 01; 53(67):45-50. PubMed ID: 16506374
    [Abstract] [Full Text] [Related]

  • 69. Functional role of matrix metalloproteinase-28 in the oral squamous cell carcinoma.
    Lin MH, Liu SY, Su HJ, Liu YC.
    Oral Oncol; 2006 Oct 01; 42(9):907-13. PubMed ID: 16730219
    [Abstract] [Full Text] [Related]

  • 70. Relationship between biomarker expression and allelic alteration in esophageal carcinoma.
    Vegh I, Santiuste AD, Colina F, Bor L, Bermejo C, Aragón A, Morán-Jiménez MJ, Gómez-Cámara A, De Salamanca RE, Moreno-González E.
    J Gastroenterol Hepatol; 2007 Dec 01; 22(12):2303-9. PubMed ID: 18031395
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
    Wang PH, Ko JL, Tsai HT, Yang SF, Han CP, Lin LY, Chen GD.
    Gynecol Oncol; 2008 Mar 01; 108(3):533-42. PubMed ID: 18177928
    [Abstract] [Full Text] [Related]

  • 74. [Expression and clinical significance of VEGF-C mRNA and CD 31 in esophageal squamous cell carcinoma].
    Ding MX, Li JC.
    Shi Yan Sheng Wu Xue Bao; 2003 Aug 01; 36(4):269-74. PubMed ID: 14574989
    [Abstract] [Full Text] [Related]

  • 75. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
    Xiao L, Tang LD.
    Ai Zheng; 2005 Jan 01; 24(1):19-22. PubMed ID: 15642194
    [Abstract] [Full Text] [Related]

  • 76. CD34 as a marker for evaluating angiogenesis in cervical cancer.
    Vieira SC, Silva BB, Pinto GA, Vassallo J, Moraes NG, Santana JO, Santos LG, Carvasan GA, Zeferino LC.
    Pathol Res Pract; 2005 Jan 01; 201(4):313-8. PubMed ID: 15991838
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma.
    Kumagai Y, Sobajima J, Higashi M, Ishiguro T, Fukuchi M, Ishibashi K, Mochiki E, Yakabi K, Kawano T, Tamaru J, Ishida H.
    Int Surg; 2015 Apr 01; 100(4):733-43. PubMed ID: 25875558
    [Abstract] [Full Text] [Related]

  • 80. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.
    Kumagai Y, Sobajima J, Higashi M, Ishiguro T, Fukuchi M, Ishibashi K, Baba H, Mochiki E, Yakabi K, Kawano T, Tamaru J, Ishida H.
    Jpn J Clin Oncol; 2014 Jun 01; 44(6):526-33. PubMed ID: 24748644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.